| mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0001 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.0002 |
| mRNA |
AZ-3146 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
| mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0004 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.0005 |
| mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0005 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.0007 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.001 |
| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
| mRNA |
QW-BI-011 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
0.002 |